Subject: 362.10941 - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Subject 362.10941

81. A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model. (September 2014)

Authors:: Brereton, Nicholas; Pennington, Becky; Ekelund, Mats; Akehurst, Ronald
Journal:: Journal of medical economics
Issue:: Volume 17:Number 9(2014)
Page Start:: 677
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

82. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy. (3rd August 2019)

Authors:: Terpos, Evangelos; Jamotte, Aurelien; Christodoulopoulou, Alexandra; Campioni, Marco; Bhowmik, Debajyoti; Kennedy, Lisa; Willenbacher, Wolfgang
Journal:: Journal of medical economics
Issue:: Volume 22:Number 8(2019)
Page Start:: 766
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

83. A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America. (4th May 2018)

Authors:: Raje, Noopur; Roodman, Garson David; Willenbacher, Wolfgang; Shimizu, Kazuyuki; García-Sanz, Ramón; Terpos, Evangelos; Kennedy, Lisa; Sabatelli, Lorenzo; Intorcia, Michele; Hechmati, Guy
Journal:: Journal of medical economics
Issue:: Volume 21:Number 5(2018)
Page Start:: 525
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

84. A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain. (31st December 2022)

Authors:: González-Juanatey, José Ramón; González-Franco, Álvaro; de Sequera, Patricia; Valls, Marta; Ramirez de Arellano, Antonio; Pomares, Elisenda; Nieves, Diana
Journal:: Journal of medical economics
Issue:: Volume 25:Number 1(2022)
Page Start:: 640
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

85. A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan. (3rd July 2018)

Authors:: Jiang, Yiling; Yang, Xiaoqin; Taniguchi, Kazuko; Petigara, Tanaz; Abe, Machiko
Journal:: Journal of medical economics
Issue:: Volume 21:Number 7(2018)
Page Start:: 687
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

86. A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden. (June 2013)

Authors:: Fredrikson, Sten; McLeod, Euan; Henry, Nathaniel; Pitcher, Ashley; Lowin, Julia; Cuche, Matthieu; Fajutrao, Liberty; Perard, Rodolphe; Bates, David; Chan, Andrew
Journal:: Journal of medical economics
Issue:: Volume 16:Number 6(2013)
Page Start:: 756
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

87. A cost-effectiveness and budget impact analysis of apremilast in patients with psoriasis in the Italian setting. (2nd April 2020)

Authors:: Barbieri, Marco; Loconsole, F.; Migliore, A.; Capri, S.
Journal:: Journal of medical economics
Issue:: Volume 23:Number 4(2020)
Page Start:: 362
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

88. A cost-effectiveness and budget impact analysis of apremilast in patients with psoriatic arthritis in Italy. (2nd April 2020)

Authors:: Capri, Stefano; Migliore, A.; Loconsole, F.; Barbieri, Marco
Journal:: Journal of medical economics
Issue:: Volume 23:Number 4(2020)
Page Start:: 353
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

89. A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain. (2nd November 2018)

Authors:: Gizzo, Salvatore; Ferrando, Marcos; Lispi, Monica; Ripellino, Claudio; Cataldo, Nazarena; Bühler, Klaus
Journal:: Journal of medical economics
Issue:: Volume 21:Number 11(2018)
Page Start:: 1096
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

90. A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK. (2nd October 2016)

Authors:: Muduma, Gorden; Odeyemi, Isaac; Pollock, Richard F.
Journal:: Journal of medical economics
Issue:: Volume 19:Number 10(2016)
Page Start:: 995
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗